Bibliografías temáticas / Oral tolerance

Literatura académica sobre el tema "Oral tolerance"

Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 6 de julio de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Índice

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Oral tolerance".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Oral tolerance"

1

Faria, Ana M. C. y Howard L. Weiner. "Oral tolerance". Immunological Reviews 206, n.º 1 (agosto de 2005): 232–59. http://dx.doi.org/10.1111/j.0105-2896.2005.00280.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

SMITH, K. M., A. D. EATON, L. M. FINLAYSON y P. GARSIDE. "Oral Tolerance". American Journal of Respiratory and Critical Care Medicine 162, supplement_3 (octubre de 2000): S175—S178. http://dx.doi.org/10.1164/ajrccm.162.supplement_3.15tac7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Weiner, Howard L., Andre Pires da Cunha, Francisco Quintana y Henry Wu. "Oral tolerance". Immunological Reviews 241, n.º 1 (13 de abril de 2011): 241–59. http://dx.doi.org/10.1111/j.1600-065x.2011.01017.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Weiner, H. L. "Oral tolerance." Proceedings of the National Academy of Sciences 91, n.º 23 (8 de noviembre de 1994): 10762–65. http://dx.doi.org/10.1073/pnas.91.23.10762.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Wu, Henry Yim y Howard L. Weiner. "Oral Tolerance". Immunologic Research 28, n.º 3 (2003): 265–84. http://dx.doi.org/10.1385/ir:28:3:265.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Garside, P. y A. McI Mowat. "Oral tolerance". Seminars in Immunology 13, n.º 3 (junio de 2001): 177–85. http://dx.doi.org/10.1006/smim.2001.0310.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Moreau, Caroline, James Trussell, Fabien Gilbert, Nathalie Bajos y Jean Bouyer. "Oral Contraceptive Tolerance". Obstetrics & Gynecology 109, n.º 6 (junio de 2007): 1277–85. http://dx.doi.org/10.1097/01.aog.0000260956.61835.6d.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Garside, Paul y Allan Mcl Mowat. "Mechanisms of Oral Tolerance". Critical Reviews™ in Immunology 17, n.º 2 (1997): 119–37. http://dx.doi.org/10.1615/critrevimmunol.v17.i2.10.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Eiks, M. L. "Oral Glucose Tolerance Tests". Diabetes Care 19, n.º 3 (1 de marzo de 1996): 271. http://dx.doi.org/10.2337/diacare.19.3.271a.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Margalit, Maya y Yaron Ilan. "Oral Tolerance for IBD". American Journal of Gastroenterology 101, n.º 12 (diciembre de 2006): 2890–91. http://dx.doi.org/10.1111/j.1572-0241.2006.00867_9.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Oral tolerance"

1

Boulton-Jones, John Robert. "Oral tolerance to soluble protein antigens in humans". Thesis, University of Edinburgh, 2001. http://hdl.handle.net/1842/22766.

Texto completo
Resumen
In this thesis, a protocol to demonstrate oral tolerance is described. Keyhole limpet haemocyanin (KLH), a neo-antigen, was used to demonstrate low dose tolerance. A control group was immunised with KLH and the subsequent immune response was assessed by delayed type hypersensitivity responses, in vitro lymphocyte proliferation to KLH and anti-KLH IgG and IgA production. Another group of volunteers was pre-fed a course of KLH prior to receiving the same immunisation schedule. The same measures of the immune response used in the control group were assessed and any differences were attributed to oral tolerance. A third group of volunteers was immunised with ovalbumin (OVA) and the immune response was measured. OVA is a common dietary protein and therefore was used to assess oral tolerance to extended courses of feeding. The group fed 50mg of KLH for 10 days demonstrated reduced DTH responses but without significant differences in in vitro lymphocyte proliferation and priming of anti-KLH IgG production. These changes demonstrated that oral tolerance can occur in the T cell compartment in humans after a short course of antigen feeding. In contrast, those volunteers immunised with OVA showed no in vitro lymphocyte proliferation or DTH responses. Anti-OVA IgA and IgA were detectable in low levels prior to immunisation but there was no increase in humoral response after immunisation. These results suggest that oral tolerance is more pronounced to an antigen that has been encountered over prolonged periods. The nature of the tolerance to KLH is not known. It may be the result of the induction of immunoregulatory cells or the induction of clonal anergy. Experiments were designed to test for the presence of immunoregulatory cells induced by feeding KLH, but no positive results were obtained. The mechanisms maintaining tolerance to OVA are likewise unknown. Attempts to demonstrate clonal anergy by reserving tolerance with IL-2 failed.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Rowsell, Paul. "Oral tolerance and immune mechanisms in food-induced diabetes". Thesis, University of Ottawa (Canada), 1996. http://hdl.handle.net/10393/9599.

Texto completo
Resumen
Diet controls $\sim$80% of type-I (insulin-dependent) diabetes in the diabetes-prone BioBreeding (BBdp) rat. This study was designed to define the relationship among diet, the gut immune system and the pancreas. BB rats were fed either a diabetogenic NIH-07 (NIH) diet or the diabetes protective, hydrolysed casein (HC) diet. Bovine serum albumin (BSA), ovalbumin (OVA), sheep red blood cells (SRBC) and NIH were given by gavage daily for 5 days. Both BBdp and the diabetes resistant BBc rat when fed NIH became unresponsive in antibody production to NIH antigens. None of the other oral antigen treatments induced tolerance. In delayed-type hypersensitivity (DTH) reactions, footpad injection of NIH resulted in lower DTH reactions and less increase in popliteal lymph node weight when animals were fed NIH than HC. We conclude that oral tolerance, both cell-mediated and humoral, to diabetogenic antigens is inducible in both strains of BB rats. This required daily feeding unlike in other rat strains. The depressed DTH reaction in the animals fed NIH indicates no link between the systemic Th1 DTH reaction to NIH and the Th1 food-induced diabetogenesis. Neonatal intrathymic injection of autoclaved NIH did not affect diabetes incidence, suggesting systemic exposure to these food antigens was not protective. Feeding neonatal BBdp rats a diabetogenic diet between 4 and 7d of age significantly delayed diabetes and reduced incidence. This effect was seen with the NIH diet and its diabetogenic component, wheat gluten. We conclude that early exposure to food diabetogens is protective against food-induced diabetes, indicating a crucial link between the local gut immune system and autoimmunity against pancreatic $\beta$ cells.
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Smith, Karen Margaret. "An investigation of oral tolerance and priming in vivo". Thesis, University of Glasgow, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269497.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Fuller, Kathleen Ann. "Oral tolerance in experimental autoimmune encephalomyelitis : the humoral arm /". The Ohio State University, 1990. http://rave.ohiolink.edu/etdc/view?acc_num=osu148767684711592.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Afuwape, Adeyemi Olutosin. "Oral tolerance and sensitisation : immunoregulation after feeding of ovalbumin and cow's milk". Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312961.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Harper, Helen Margaret. "The induction of immune responses in the murine small intestine". Thesis, University of Bristol, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.389589.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Dieti, Anastasia. "Influence of guar galactomannan on antigen absorption and induction of immunological oral tolerance". Thesis, King's College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.433117.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Meyer, Abbie L. "Oral tolerance to myelin basic protein in mice : suppression of experimental autoimmune encephalomyelitis /". The Ohio State University, 1996. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487934589975749.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Rider, Kelly N. "Examination of the effect of reduction of probiotic species Lactobacillus due to broad spectrum antibiotic treatment on oral tolerance". Muncie, Ind. : Ball State University, 2009. http://cardinalscholar.bsu.edu/442.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

McGarry, Robert Gerard. "Modelling insulin/glucose dynamics and application to the analysis of oral glucose tolerance tests". Thesis, Queen's University Belfast, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.335562.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Oral tolerance"

1

Morteau, Olivier. Oral tolerance: The response of the intestinal mucosa to dietary antigens. Georgetown, TX: Landes Bioscience, 2001.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Morteau, Olivier. Oral tolerance: The response of the intestinal mucosa to dietary antigens. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Morteau, Olivier. Oral tolerance: The response of the intestinal mucosa to dietary antigens. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

D, Matthews Dawn, ed. Diabetes sourcebook: Basic consumer health information about Type 1 diabetes (insulin-dependent or juvenile-onset diabetes), Type 2 diabetes (noninsulin-dependent or adult-onset diabetes, gestational diabetes, impaired glucose tolerance (IGT), and related complications, such as amputation, eye disease, gum disease, nerve damage, and end-stage renal disease : including facts about insulin, oral diabetes medications, blood sugar testing, and the role of exercise and nutrition in the control of diabetes : along with a glossary and resources for further help and information. 3a ed. Detroit, Mich: Omnigraphics, 2003.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Alexieiwcz, Tomasz. Walka tolerancja dialog współpraca: Wobec sekt i nowych ruchów religijnych : zapis sympozjum przygotowanego przez Dominkański Ośrodek Informacji o Sektach i Nowych Ruchach Religijnych w Warszawie oraz Kolegium Filozoficzno-Teologiczne Polskiej Prowincji Dominikanów w Warszawie, 17 marca 2004 roku. [Poznań]: IW Jerozolima, 2010.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Oral tolerance: Mechanisms and applications. New York, N.Y: New York Academy of Sciences, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Morteau, Olivier. Oral Tolerance: The Response of the Intestinal Mucosa to Dietary Antigens. Springer, 2010.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

(Editor), Howard L. Weiner y Lloyd F. Mayer (Editor), eds. Oral Tolerance: Mechanisms and Applications (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

(Editor), Howard L. Weiner, Lloyd F. Mayer (Editor) y Warren Strober (Editor), eds. Oral Tolerance: New Insights and Prospects for Clinical Application (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Weiner, Howard L. Oral Tolerance: Mechanisms and Applications (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Oral tolerance"

1

Weiner, Howard L. "Oral Tolerance". En Therapeutic Immunosuppression, 159–82. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0765-8_7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Klimov, Vladimir V. "Food Allergies and Oral Tolerance". En Textbook of Allergen Tolerance, 185–215. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04309-3_7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Jensen, Chad D., Amy F. Sato, Elissa Jelalian, Elizabeth R. Pulgaron, Alan M. Delamater, Chad D. Jensen, Amy F. Sato et al. "Oral Glucose Tolerance Test (OGTT)". En Encyclopedia of Behavioral Medicine, 1389. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_769.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Varshney, Pooja y A. Wesley Burks. "Oral Tolerance and Eosinophilic Esophagitis". En Eosinophilic Esophagitis, 339–50. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-515-6_26.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Carrillo, Adriana. "Oral Glucose Tolerance Test (OGTT)". En Encyclopedia of Behavioral Medicine, 1567. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_769.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Wildner, G. y S. R. Thurau. "Oral Tolerance in Autoimmune Uveitis". En Uveitis Update, 67–76. Basel: KARGER, 1999. http://dx.doi.org/10.1159/000060757.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Murch, S. "Oral Tolerance and Gut Maturation". En Nestl� Nutrition Workshop Series: Pediatric Program, 133–51. Basel: KARGER, 2004. http://dx.doi.org/10.1159/000077647.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Czerkinsky, C., J. B. Sun y J. Holmgren. "Oral Tolerance and Anti-Pathological Vaccines". En Defense of Mucosal Surfaces: Pathogenesis, Immunity and Vaccines, 79–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59951-4_5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Jain, Aakanchha, Richa Jain y Sourabh Jain. "To Perform Oral Glucose Tolerance Test". En Basic Techniques in Biochemistry, Microbiology and Molecular Biology, 211–12. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-4939-9861-6_48.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Fuhrmann, K. "Targets in Oral Glucose Tolerance Testing". En Carbohydrate Metabolism in Pregnancy and the Newborn · IV, 227–37. London: Springer London, 1989. http://dx.doi.org/10.1007/978-1-4471-1680-6_20.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Oral tolerance"

1

Popov, Sergey V., Pavel A. Markov, Ida R. Nikitina, Raisa G. Ovodova y Yury S. Ovodov. "EFFECTS OF PLANT POLYSACCHARIDES ON PHAGOCYTES AND ORAL TOLERANCE". En XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.674.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Perpi�an, Gilberto, Erika Severeyn, Sara Wong y Miguel Altuve. "Nonlinear Heart Rate Variability Measures During the Oral Glucose Tolerance Test". En 2017 Computing in Cardiology Conference. Computing in Cardiology, 2017. http://dx.doi.org/10.22489/cinc.2017.148-302.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Quintero, Lersi, Gilberto Perpinan, Erika Severeyn, Miguel Altuve y Sara Wong. "Nonlinear parameters of heart rate variability during oral glucose tolerance test". En 2016 XXI Symposium on Signal Processing, Images and Artificial Vision (STSIVA). IEEE, 2016. http://dx.doi.org/10.1109/stsiva.2016.7743303.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Dritsas, Elias, Sotiris Alexiou, Ioannis Konstantoulas y Konstantinos Moustakas. "Short-term Glucose Prediction based on Oral Glucose Tolerance Test Values". En 15th International Conference on Health Informatics. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0010974200003123.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Kawakami, Hidenori, Toshiyuki KOYA, Yosuke Kimura, Cristiane Yamabayashi, Toshiki Furukawa, Takuro Sakagami, Hiroshi Kagamu, Takashi Hasegawa, Eiichi Suzuki y Ichiei Narita. "IL-17 Eliminates Therapeutic Effects Of Oral Tolerance In Murine Airway Allergic Inflammation". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4394.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

González-Domínguez, Raúl, Álvaro González-Domínguez y Alfonso Lechuga-Sancho. "Comparison of the metabolomic signature of diabetes and the oral glucose tolerance test". En 4th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2018. http://dx.doi.org/10.3390/ecmc-4-05571.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

NAKAYA, A., H. HISHIGAKI y S. MORISHITA. "MINING THE QUANTITATIVE TRAIT LOCI ASSOCIATED WITH ORAL GLUCOSE TOLERANCE IN THE OLETF RAT". En Proceedings of the Pacific Symposium. WORLD SCIENTIFIC, 1999. http://dx.doi.org/10.1142/9789814447331_0035.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

DeLeo, Jim, Carl Leonard y Anne E. Sumner. "Constructing clinical scoring systems to determine the need for an oral glucose tolerance test". En 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta). IEEE, 2009. http://dx.doi.org/10.1109/ijcnn.2009.5178936.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Chierici, Marco, Gianluigi Pillonetto, Gianna Toffolo y Claudio Cobelli. "Glucose Production by Deconvolution in Intravenous and Oral Glucose Tolerance Tests: Role of Output Variable". En Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.259961.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Chierici, Marco, Gianluigi Pillonetto, Gianna Toffolo y Claudio Cobelli. "Glucose Production by Deconvolution in Intravenous and Oral Glucose Tolerance Tests: Role of Output Variable". En Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.4398587.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Oral tolerance"

1

Chatila, Talal. Mechanisms of Oral Tolerance Breakdown in Food Allergy. Fort Belvoir, VA: Defense Technical Information Center, octubre de 2013. http://dx.doi.org/10.21236/ada602791.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Li, Yaodong, Zuoqiong Zhou, Yiping WANG, Gang MAI, Yangyun HANG, Lingling ZHU, Ming ZHAO et al. Comparison of oral sodium phosphate tablets and polyethylene glycol lavage solution for colonoscopy preparation: A systematic review and meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, mayo de 2023. http://dx.doi.org/10.37766/inplasy2023.5.0013.

Texto completo
Resumen
Review question / Objective: To systematically compare the bowel cleaning ability, patient tolerance and safety of oral sodium phosphate tablets (NaPTab) and oral polyethylene glycol electrolyte lavage solution (PEGL) to inform clinical decision making. Review question include: 1) patient populations with an indication for colonoscopy, including outpatients or inpatients requiring diagnosis or treatment, 2) randomized controlled trial (RCT) study designs, 3) a sodium phosphate tablet intervention group, 4) a control group receiving PEGL administered orally or by nasogastric tube, and 5) outcome measures including cleansing quality, adverse effects, patient acceptance, and changes in serum electrolytes after preparation.
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Field, Kevin, Maxim Gussev y Yukinori Yamamoto. FY-13 FCRD Milestone M3FT-13OR0202311 Weldability of ORNL Accident Tolerant Fuel Cladding Model Alloys For Thin Walled Tubes. Office of Scientific and Technical Information (OSTI), julio de 2013. http://dx.doi.org/10.2172/1149392.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Bell, Gary L., Mark Christopher Vance, Kurt A. Terrani, Lance Lewis Snead y Chunghao Phillip Shih. The Production Process, Thermophysical Properties, and Quality Assurance Process for the Provision of Enhanced Accident Tolerant Fuels: ORNL Rodlets for the ATR ATF-1 Experiment. Office of Scientific and Technical Information (OSTI), octubre de 2013. http://dx.doi.org/10.2172/1105930.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Saldanha, Ian J., Gaelen P. Adam, Ghid Kanaan, Michael L. Zahradnik, Dale W. Steele, Valery A. Danilack, Alex Friedman Peahl, Kenneth K. Chen, Alison M. Stuebe y Ethan M. Balk. Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), junio de 2023. http://dx.doi.org/10.23970/ahrqepccer261.

Texto completo
Resumen
Objectives. This systematic review assesses postpartum care for individuals up to 1 year after pregnancy. We addressed two Key Questions (KQs) related to the comparative effectiveness and harms of: (1) alternative strategies for postpartum healthcare delivery and (2) extension of postpartum health insurance coverage. Data sources and review methods. We searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov from inception to November 16, 2022, to identify comparative studies in the United States and Canada (for KQ 1) and in the United States (for KQ 2). We extracted study data into the Systematic Review Data Repository Plus (SRDR+; https://srdrplus.ahrq.gov). We assessed the risk of bias and evaluated the strength of evidence (SoE) using standard methods. The protocol was registered in PROSPERO (registration number CRD42022309756). Results. We included 50 randomized controlled trials (RCTs) and 14 nonrandomized comparative studies (NRCSs) for KQ 1 and 28 NRCSs for KQ 2. Risk of bias was moderate to high for most RCTs and all NRCSs. KQ 1: Regarding where healthcare is provided, for general postpartum care (6 studies), whether the visit is at home/by telephone or at the clinic may not impact depression or anxiety symptoms (low SoE). For breastfeeding care (8 studies), whether the initial visit is at home or at the pediatric clinic may not impact depression symptoms up to 6 months postpartum, anxiety symptoms up to 2 months, hospital readmission up to 3 months (summary relative risk [RR] 1.38, 95% confidence interval [CI] 0.90 to 2.13; 4 studies), or other unplanned care utilization up to 2 months (low SoE, all outcomes). Regarding how care is provided, for general postpartum care (4 studies), integration of care (i.e., care provided by multiple types of providers) may not impact depression symptoms or substance use up to 1 year (low SoE). Regarding when care is provided, for contraceptive care (9 studies), compared with later contraception, earlier contraception start is probably associated with comparable continued IUD use at 3 and 6 months but greater implant use at 6 months (summary RR 1.36, 95% CI 1.13 to 1.64; 2 RCTs) (moderate SoE). Regarding who provides care, for breastfeeding care (19 studies), compared with no peer support, peer support is probably associated with higher rates of any breastfeeding at 1 month (summary effect size [ES] 1.13, 95% CI 1.03 to 1.24; 4 studies) and 3 to 6 months (summary ES 1.22, 95% CI 1.06 to 1.41; 4 studies) and of exclusive breastfeeding at 1 month (summary ES 1.10, 95% CI 1.02 to 1.19; 6 studies) but probably yields comparable rates of exclusive breastfeeding at 3 months and nonexclusive breastfeeding at 1 and 3 months (all moderate SoE). Compared with no lactation consultant, breastfeeding care by a lactation consultant is probably associated with higher rates of any breastfeeding at 6 months (summary ES 1.43, 95% CI 1.07 to 1.91; 3 studies) but not at 1 month or 3 months (all moderate SoE). Lactation consultant care may not be associated with rates of exclusive breastfeeding at 1 or 3 months (moderate SoE). Regarding coordination/management of care, provision of reminders for testing is probably associated with greater adherence to oral glucose tolerance testing up to 1 year postpartum but not random glucose testing or hemoglobin A1c testing (moderate SoE). Regarding use of information or communication technology (IT; 8 studies), IT use for breastfeeding care is probably associated with comparable rates of any breastfeeding at 3 months and 6 months and of exclusive breastfeeding at 3 months (all moderate SoE). Because of sparse evidence, inconsistent results, and/or the lack of reporting of prioritized outcomes, no conclusions related to interventions targeting healthcare providers are feasible (4 studies). KQ 2: Regarding health insurance (28 studies), more comprehensive health insurance is probably associated with greater attendance at postpartum visits (moderate SoE) and may be associated with fewer preventable readmissions and emergency room visits (low SoE). Conclusion. Most studies included in this systematic review enrolled predominantly healthy postpartum individuals. Researchers should therefore design studies that, either entirely or in part, enroll individuals at high risk of postpartum complications due to chronic conditions, pregnancy-related conditions, or incident or newly diagnosed conditions. New high-quality research is needed, especially for interventions targeting healthcare providers and the impact of more comprehensive or extended health insurance on postpartum health. Patient-reported outcomes, such as quality of life, should also be reported. Researchers should report separate data for various population subgroups, which could help close gaps in health outcomes among the races of postpartum individuals in the United States.
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Oral tolerance" para tipos de fuentes particulares:
Artículos de revistas Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía